Anthracycline-related Cardiotoxicity in Breast Cancer

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-02-23
Clinical Trial Update: Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab [NA]
A clinical trial update from Virginia Commonwealth University evaluating cardiovascular health education via virtual reality for breast canc…